Read every efficacy figure as a within-trial result under the conditions of that specific study not as a direct duel, and not as a therapeutic claim
These included amyotrophic lateral sclerosis (ALS), pulmonary fibrosis (PF), acute respiratory distress syndrome (ARDS), Duchenne muscular dystrophy (DMD), cystic fibrosis (CF), Huntingtons disease (HD), pulmonary hypertension (PH), cytokine release syndrome (CRS), frontotemporal dementia (FTD), and graft-versus-host disease (GVHD)., All selected diseases were confirmed to be classified as rare diseases by Orphanet ( a widely used global database for rare diseases
M., Chapple, C
Cao HY, Lian JN, Lin ZS, Zhu ZW, Wang H,Wang HY
Rothschild and Bishop, 2020
Gogtay N, Sporn A, Clasen LS, Nugent III TF, Greenstein D, Nicolson R et al (2004)